Lars Bertram

发表

Blood-based multivariate methylation risk score for cognitive impairment and dementia

K. Blennow, P. Scheltens, O. Blin, 2023, medRxiv.

Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning

Sebastiaan, K. Blennow, P. Scheltens, 2022, Genome Medicine.

Entorhinal cortex EWAS meta-analysis highlights four novel loci showing differential methylation in Alzheimer’s disease

C. Lill, L. Parkkinen, J. Fuss, 2021 .

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer’s Disease Pathology

R. Dobson, K. Blennow, J. Molinuevo, 2020, Journal of Alzheimer's disease : JAD.

Replication study of plasma proteins relating to Alzheimer’s 1 pathology

J. Molinuevo, P. Scheltens, P. Visser, 2021 .

Relationship between five Epigenetic Clocks, Telomere Length and Functional Capacity assessed in Older Adults: Cross-sectional and Longitudinal Analyses

V. Regitz-Zagrosek, L. Bertram, I. Demuth, 2021, medRxiv.

Genome-wide meta-analysis of short-tandem repeats for Parkinson’s disease risk using genotype imputation

J. Bronstein, L. Parkkinen, K. Paul, 2024, Brain communications.

Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer’s disease CSF profile of neuronal injury and inflammation

P. Scheltens, F. Barkhof, G. Frisoni, 2022, Molecular Psychiatry.

Genome-wide QTL mapping across three tissues highlights several Alzheimer’s and Parkinson’s disease loci potentially acting via DNA methylation

U. Lindenberger, C. Solé-Padullés, K. Walhovd, 2023, medRxiv.

Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimerâ€TMs disease CSF profile of neuronal injury and inflammation

C. Broeckhoven, K. Sleegers, O. Blin, 2022 .

Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.

K. Sleegers, P. Proitsi, B. Tijms, 2024, Computers in biology and medicine.